.-
.- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
scottish widows has its eyes on the master trust prize .
![](#dana-rohrabacher-gty-hb-180516_hpmain_16x9t_240.jpg)
$17
OFF DEAL
OFF DEAL
50%
OFF DEAL
OFF DEAL
GET DEAL
181 Used Today
$20
OFF DEAL
OFF DEAL
GET DEAL
200 Used Today